Choline or CDP-choline attenuates coagulation abnormalities and prevents the development of acute disseminated intravascular coagulation in dogs during endotoxemia

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 4, 2010, Pages 339-348

  Yilmaz, Zeki ^a   Ozarda, Yesim ^b   Cansev, Mehmet ^a   Eralp, Oya ^a   Kocaturk, Meric ^a   Ulus, Ismail H ^c  

^a ULUDAG UNIVERSITY   (Turkey)

^b Department of Biochemistry ^*  (Turkey)

^c ACIBADEM UNIVERSITY   (Turkey)

Author keywords

CDP choline; Choline; DIC; Dog; Endotoxin; Hemostasis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; CHOLINE; CITICOLINE; D DIMER; ENDOTOXIN; FIBRINOGEN;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOG; ENDOTOXEMIA; FEMALE; HEMOSTASIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA;

ANIMALS; BLOOD COAGULATION; CHOLINE; CYTIDINE DIPHOSPHATE CHOLINE; DISSEMINATED INTRAVASCULAR COAGULATION; DOGS; ENDOTOXEMIA; ENDOTOXINS; FEMALE; MALE;

EID: 77951911170     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328338ce31     Document Type: Article

References (38)

1. Amersfoorth ESV, Berkel TJCV, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Mic Rev 2003; 16: 379-414.
2. Jonge E, Levi M, Poll T. Coagulation abnormalities in sepsis: relation with inflammatory responses. Curr Opin Crit Care 2000; 6: 317-322.
3. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997; 23: 379-385.
4. Levi M, de Jonge E, van der Poll T. Sepsis and disseminated intravascular coagulation. J Thromb Thrombolyis 2003; 16: 43-47.
5. Wurtman RJ, Cansev M, Ulus IH. Choline and its products acetylcholine and phosphatidylcholine. In Lajtha A, editor. Handbook of neurochemistry and molecular neurobiology, Vol. 8. Berlin-Heidelberg: Springer-Verlag; 2009, pp. 443-501.
6. Rivera CA, Wheeler MD, Enomoto N, Thurman RG. A choline rich diet improves survival in a rat model of endotoxin shock. Am J Physiol 1998; 275: 862-867.
7. Nolan JP, Ali MV. Endotoxin and the liver. Toxicity in rats with choline deficient fatty livers. Proc Soc Exp Biol Med 1968; 129: 29-33.
8. Eastin CE, McClain CJ, Lee EY, Bagby GJ, Chawla RK. Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. Alcohol Clin Exp Res 1997; 21: 1037-1041.
9. Ilcol YO, Yilmaz Z, Ulus IH. Endotoxin alters serum-free choline and phospholipid-bound choline concentrations, and choline administration attenuates endotoxin-induced organ injury in dogs. Shock 2005; 24: 288-293.
10. Ilcol YO, Yilmaz Z, Cansev M, Ulus IH. Choline or CDP-choline alters serum lipid responses to endotoxin in dogs and rats: involvement of the peripheral nicotinic acetylcholine receptors. Shock 2009; 32: 286-294.
11. Yilmaz Z, Ilcol YO, Torun S, Ulus IH. Intravenous administration of choline or CDP-choline improves platelet count and platelet closure times in endotoxin-treated dogs. Shock 2006; 25: 73-79.
12. Savci V, Ulus IH. Cardiovascular effects of central choline during endotoxin shock in the rat. J Cardivasc Pharmacol 1997; 30: 667-675.
13. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta, Ochani M, Ochani K, Yang L, et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholinemediated signaling. Mol Med 2008; 14: 567-574.
14. Adibhatla RM, Hatcher JF. Cytidine 5'-diphosphocholine (CDP-Choline) in stroke and other CNS disorders. Neurochem Res 2005; 30: 15-23.
15. Wurtman RJ, Regan M, Ulus I, Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol 2000; 60: 989-992.
16. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 2007; 117: 289-296.
17. Fujii T, Takata-Takatori Y, Kawashima K. Basic and clinical aspects of nonneuronal acetylcholine: expression of an independent, nonneuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J Pharmacol Sci 2008; 106: 186-192.
18. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the nonneuronal cholinergic system in humans. Br J Pharmacol 2008; 154: 1558-1571.
19. Buyukuysal LR, Ulus IH, Aydin S, Kiran BK. 3, 4-Diaminopyridine and choline increase acetylcholine release in rat striatum. Eur J Pharmacol 1995; 281: 79-185.
20. Ulus IH, Millington WR, Buyukuysal RL, Kiran BK. Choline as an agonist: determination of its agonistic potency on cholinergic receptors. Biochem Pharmacol 1988; 14: 2747-2755.
21. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330.
22. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, et al., Sepsis Study Group. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism [ISRCTN74215569]. Critical Care 2004; 8: 82-90.
23. Svan Devanter SDH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520-2528.
24. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic pathway in patients with severe sepsis and septic shock. Crit Care Med 1998; 26: 2005-2009.
25. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 1996; 88: 881-886.
26. Wilson RF, Mammen EF, Tyburski JG, Warsow KM, Kubinec SM. Antithrombin levels related to infections and outcome. J Trauma 1996; 40: 384-387.
27. Meyer EM, Baker SP. Effects of choline augmentation on acetylcholine release in rat atrial minces. Life Sci 1986; 39: 1307-1315.
28. Ilcol YO, Gurun MS, Taga Y, Ulus IH. Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated acetylcholine release from the rat minced pancreas in vitro. Eur J Biochem 2003; 270: 991-999.
29. llcol YO, Cansev M, Yilmaz MS, Hamurtekin E, Ulus IH. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions. Neurosci Lett 2008; 431: 71-76.
30. Cansev M, Yilmaz MS, llcol YO, Hamurtekin E, Ulus IH. Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. Eur J Pharmacol 2007; 577: 129-142.
31. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
32. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla, Li JH, et al. Nicotinic acetylcholine receptor a7 subunit is essential regulator of inflammation. Nature 2003; 421: 384-388.
33. Van Westerloo DJ, Giebelen IAJ, Meijers JCM, Daalhuisen J, De Vos AF, van Der Poll T. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 2006; 4: 1997-2002.
34. Hamano R, Takahashi HK, Iwagaki H, Yoshino T, Nishibori M, Tanaka N. Stimulation of a7-nicotinic acetylcholine receptor inhibits CD14 and the tolllike receptor 4 expression inhuman monocytes. Shock 2006; 26: 358-364.
35. Takahashi HK, Iwagaki H, Hamano R, Kanke T, Liu K, Sadamori H, et al. The immunosuppressive effects of nicotine during mixed lymphocyte reaction. Eur J Pharmacol 2007; 559: 69-74. (Pubitemid 46274647)
36. Fuentes JM, Fulton WB, Nino D, Talamini MA, Maio AD. Atropine treatment modifies LPS-induced inflammatory response and increases survival. Inflamm Res 2008; 57: 111-117.
37. Berczi I. Neurohormonal host defense in endotoxic shock. Ann N Y Acad Sci 1998; 840: 787-802.
38. Lominadze D, Dean WL, Tyag SC, Roberts AM. Mechanism of fibrinogeninduced microvascular dysfunction during cardiovascular disease. Acta Physiol (Oxf) 2010; 198: 1-13.